TerminatedNCT02353351

ADVANCE ASO AMPLATZER™ Atrial Septal Occluder Post Market Surveillance Study

Studying Interatrial communication

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Abbott Medical Devices
Principal Investigator: Ashish Oza
Abbott Medical Devices
Intervention: atrial septal occluder(device)
Enrollment: 602 target
Eligibility: All sexes
Timeline: 2015 – 2017

Study locations (30)

University of Alabama, Birmingham, Alabama, United States
University of Arizona, Tucson, Arizona, United States
University of Arkansas, Little Rock, Arkansas, United States
Children's Hospital Los Angeles, Los Angeles, California, United States
Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
University of Southern California, Los Angeles, California, United States
Ronald Reagan UCLA Medical Center, Los Angeles, California, United States
Valley Children's Hospital, Madera, California, United States
Stanford University Medical Center, Palo Alto, California, United States
Huntington Memorial Hospital, Pasadena, California, United States
Rady Children's Hospital, San Diego, California, United States
Yale New Haven Hospital, New Haven, Connecticut, United States
Nemours/Alfred I. duPont Hospital for Children, Wilmington, Delaware, United States
Children's National Medical Center, Washington D.C., District of Columbia, United States
Clearwater Cardiovascular Consultants, Clearwater, Florida, United States
+15 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02353351 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication →

← Back to all trials